When was Rouken Bio founded?

Rouken Bio was founded in 2015.

Where is Rouken Bio located?

Rouken Bio is headquartered in East Kilbride, United Kingdom.

How many employees does Rouken Bio have?

As of Sep 30, 2026, the latest employee count at Rouken Bio is 118.

Where does Rouken Bio rank among its competitors?

Rouken Bio ranks 56th amongst 408 active competitors, of which 35 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was InduPro, which secured $77M in Aug, 2026.

Who are the top competitors of Rouken Bio?

Rouken Bio's top competitors include LabCorp, Cytel and Precision for Medicine. Among them, InduPro secured the most recent funding round in August, 2026.

Rouken Bio - 2026 Company Profile & Competitors

Rouken Bio is an unfunded company based in East Kilbride (United Kingdom), founded in 2015. It operates as a Biotechnology company providing immunology-centered contract research organization services. Rouken Bio has not raised any funding yet. The company has 408 active competitors, including 35 funded and 62 that have exited. Its top competitors include companies like LabCorp, Cytel and Precision for Medicine.

Company Details

RoukenBio is a contract research organization (CRO) that provides immunology research services to an international client base. The company specializes in bespoke cell-based models that replicate biological processes to support drug development and therapeutic discovery. With a strong focus on immunology-centered research, RoukenBio offers a range of services, including cell-based assays and cell engineering. The company is headquartered in Motherwell, Scotland, and is committed to advancing human health through innovative research solutions.

Key Metrics

Founded Year

2015

Location

East Kilbride, United Kingdom

Stage

Unfunded

Ranked

56^th among 408 active competitors

Employee Count

118 as on Sep 30, 2026

Similar Companies

LabCorp & 452 more

View Rouken Bio's full profile

Rouken Bio has not raised any funding rounds yet.

Rouken Bio's employee count trend

Rouken Bio has 118 employees as of Sep 26. Here is Rouken Bio's employee count trend over the years:

Uncover Rouken Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Rouken Bio include LabCorp, Cytel and Precision for Medicine. Here is the list of Top 10 competitors of Rouken Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	LabCorp 1969, Burlington (United States), Public	Provider of laboratory tests for physicians	-	The MassMutual Trust Company, F.S.B., JANA Partners ... & 4 others	80/100
2nd	Cytel 1987, Cambridge (United States), Acquired	Provider of data analysis and statistical solutions for the life sciences industry	$2M	New Mountain Capital, Autonomy Ventures & 3 others	67/100
3rd	Precision for Medicine 2013, United States, Late Stage	Provider of clinical research services, laboratory services, and data intelligence	$150M	Oak HC/FT, Oak Investment Partners & 2 others	66/100
4th	Veeda Lifesciences 2004, Ahmedabad (India), Series B	Provider of clinical research services for drug development and testing	$83.3M	Actis, QRG Investments and Holdings & 51 others	63/100
5th	Charles River Laboratories 1947, Wilmington (United States), Public	Provider of drug discovery and preclinical development services	-	Foundation for Chemistry Research & Initiatives, Sagard ... & 9 others	62/100
6th	Taimei Technology 2013, Pleasanton (United States), Public	A digital intelligence platform focused on the life sciences sector	$194M	Shanghai Ivy Capital, Tiger Global Management ... & 9 others	60/100
7th	Frontage Laboratories 2001, Exton (United States), Public	Global pharmaceutical development organization providing comprehensive drug discovery and development services	$10.2M	Baird Capital, TF Capital	59/100
8th	Medimaps Group 2006, Geneva (Switzerland), Series B	Developer of AI-powered bone health assessment software	$20M	Swisscanto, Verve Ventures & 2 others	54/100
9th	QPS 1995, Newark (United States), Acquired	Global CRO providing bioanalysis, preclinical, and clinical research services	-	First Analysis, Graycliff Partners & 1 others	53/100
10th	InduPro 2022, Seattle (United States), Series B	Provides science to manipulate protein interactions and explore new possibilities for treating patients	$162M	The Column Group, Vida Ventures & 8 others	52/100
56th	Rouken Bio 2015, East Kilbride (United Kingdom), Unfunded	Biotechnology company providing immunology-centered contract research organization services	-	-	36/100